Company Valuation: BioRem Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2024 2025 2026 2027
Market Cap 1 49.17 43.52 55.79 -
Change - -11.49% 28.2% -
Enterprise Value (EV) 49.17 43.52 55.79 55.79
Change - -11.49% 28.2% 0%
P/E 19.1x 10.4x 10.1x 8x
PBR - - - -
PEG - 0.2x 0.3x 0.3x
Capitalization / Revenue - - 1.07x 0.95x
EV / Revenue - - 1.07x 0.95x
EV / EBITDA - - 6.06x 5.07x
EV / EBIT - - - -
EV / FCF - - 9x 7.25x
FCF Yield - - 11.1% 13.8%
Dividend per Share 2 - - - -
Rate of return - - - -
EPS 2 0.16 0.26 0.34 0.43
Distribution rate - - - -
Net sales 1 - - 52.1 58.9
EBITDA 1 - - 9.2 11
EBIT - - - -
Net income 3.044 4.817 - -
Net Debt - - - -
Reference price 2 3.050 2.700 3.440 3.440
Nbr of stocks (in thousands) 16,120 16,117 16,217 -
Announcement Date 4/16/25 4/20/26 - -
1CAD in Million2CAD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
10.12x - - - 40.03M
22.15x2.86x15.31x1.39% 10.01B
207.22x3.26x20.45x - 4.07B
17.88x2.65x12.49x1.92% 3.49B
27.5x - - - 1.29B
Average 56.97x 2.92x 16.08x 1.66% 3.78B
Weighted average by Cap. 61.53x 2.91x 15.94x 1.53%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. BRM Stock
  4. Valuation BioRem Inc.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!